HHS, FDA Announce Plans for Clinical Trial Rule Changes
December 17, 2021 at 03:42 PM EST
In the federal 2021 Fall Unified Agenda of Regulatory and Deregulatory Actions, the FDA and the Department of Health and Human Services (HHS) announced 2022 plans for several proposed rules that affect clinical trial operations, including harmonizing the FDA’s regulations with the Common Rule, which was revised in 2019.
According to the Unified Agenda, the FDA will issue an N... Read More
